SCOTT LANCE: Open Payments
NPI 1467462101 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,448 in 77 payments from 13 companies in 2025. Trend: 2023 $1,309 · 2024 $1,569 · 2025 $1,448
Food & beverage: $1,448
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 13 | $260 |
| Vanda Pharmaceuticals Inc. | 9 | $258 |
| ABBVIE INC. | 18 | $219 |
| Neurocrine BioSciences, Inc. | 8 | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $99 |
| Teva Pharmaceuticals USA, Inc. | 4 | $88 |
| Alkermes, Inc. | 4 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $75 |
| Lundbeck LLC | 4 | $73 |
| Otsuka America Pharmaceutical, Inc. | 4 | $71 |
Products named: Auvelity, HETLIOZ, VRAYLAR, INGREZZA, REXULTI, TRINTELLIX, AUSTEDO XR, ARISTADA.
Industry payments across KY — which companies pay providers there.
